Breast Neoplasms × Endocrine × 30 days × Clear all
NCT03157128 2026-04-16

LIBRETTO-001

Eli Lilly and Company

Phase 1/2 Active not recruiting
857 enrolled 24 charts 6 FDA
NCT05461430 2026-04-13

TraveraRTGx

Travera Inc

Completed
72 enrolled